# Non-inferiority and Safety Study of EuTCV Compared to Typbar-TCV in Healthy 6 Months-45 Years Aged Participants

> **NCT04830371** · PHASE2,PHASE3 · COMPLETED · sponsor: **EuBiologics Co.,Ltd** · enrollment: 444 (actual)

## Conditions studied

- Typhoid Fever

## Interventions

- **BIOLOGICAL:** EuTCV (Vi-CRM Typhoid conjugate vaccine)
- **BIOLOGICAL:** Typbar-TCV

## Key facts

- **NCT ID:** NCT04830371
- **Lead sponsor:** EuBiologics Co.,Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-07
- **Primary completion:** 2021-03-18
- **Final completion:** 2021-08-01
- **Target enrollment:** 444 (ACTUAL)
- **Last updated:** 2021-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04830371

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04830371, "Non-inferiority and Safety Study of EuTCV Compared to Typbar-TCV in Healthy 6 Months-45 Years Aged Participants". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04830371. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*